Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Deficit (Unaudited)

v3.19.1
Condensed Consolidated Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2017 $ 45,717 $ 22,127,796 $ (22,854,556) $ (681,043)
Balance, shares at Dec. 31, 2017 45,717,635      
Beneficial conversion feature on convertible note payable   260,000   260,000
Stock option exercise compensation   15,000    
Accretion of stock option expense   1,444,933   1,444,933
Shares issued for conversion of accrued compensation $ 12,695 650,760   663,455
Shares issued for conversion of accrued compensation, shares 12,694,893      
Common shares issued for conversion of debt $ 137 105,696   105,833
Common shares issued for conversion of debt, shares 136,894      
Common shares issued for services and prepaid services $ 81 68,669   68,750
Common shares issued for services and prepaid services, shares 80,843      
Exercise of stock options $ 323 9,677   10,000
Exercise of stock options, shares 323,373      
Net loss     (2,286,848) (2,286,848)
Balance at Mar. 31, 2018 $ 58,953 24,682,531 (25,141,404) (399,920)
Balance, shares at Mar. 31, 2018 58,953,638      
Balance at Dec. 31, 2018 $ 80,459 31,863,693 (32,759,275) (815,123)
Balance, shares at Dec. 31, 2018 80,459,006      
Stock option exercise compensation 7,500 7,500
Common shares issued for services and prepaid services $ 685 113,775 114,460
Common shares issued for services and prepaid services, shares 685,060      
Accretion of stock-based compensation 909,375 909,375
Accretion of stock option and warrant expense   586,934   586,934
Net loss (2,360,423) (2,360,423)
Balance at Mar. 31, 2019 $ 81,144 $ 33,481,277 $ (35,119,698) $ (1,557,277)
Balance, shares at Mar. 31, 2019 81,144,066